InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

GLTO Stock Earnings: Galecto Beats EPS for Q2 2024

By InvestorPlace Earnings

GLTO stock results show that Galecto beat analyst estimates for earnings per share the second quarter of 2024.

FLGC Stock Earnings: Flora Growth Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

FLGC stock results show that Flora Growth missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

CTXR Stock Earnings: Citius Pharma Meets EPS for Q3 2024

By InvestorPlace Earnings

CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the third quarter of 2024.

CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q2 2024

By InvestorPlace Earnings

CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Load More